Old Web
English
Sign In
Acemap
>
authorDetail
>
Natalie Hearmon
Natalie Hearmon
Hepatitis C virus
Medicine
cost effectiveness
Hepatitis C
Population
4
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy
2021
François Girardin
Chris Painter
Natalie Hearmon
Lucy Eddowes
Stefan Kaiser
Francesco Negro
Nathalie Vernaz
Show All
Source
Cite
Save
Citations (0)
Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost-effectiveness analysis
2019
Journal of Viral Hepatitis
François Girardin
Natalie Hearmon
Francesco Negro
Lucy Eddowes
Philip Bruggmann
Erika Castro
Show All
Source
Cite
Save
Citations (10)
Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting
2019
Clinical Infectious Diseases
François Girardin
Natalie Hearmon
Erika Castro
Francesco Negro
Lucy Eddowes
Laurent Getaz
Hans Wolff
Show All
Source
Cite
Save
Citations (8)
OP44 Cost-Effectiveness Of Hepatitis C Virus Screening In Swiss Prisons Using Rapid Tests
2017
International Journal of Technology Assessment in Health Care
François Girardin
Natalie Hearmon
Erika Castro
Francesco Negro
Rodolphe Perard
Anita Schnyder
Lucy Eddowes
Laurent Getaz
Hans Wolff
Show All
Source
Cite
Save
Citations (0)
1